Replies to post #43315 on Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

FDA is waiting on data for Zyesami IV. The Zyesami inhaled form would be used to pursue about (5) other lung indications, among them ARDS and COPD.

[Clef]

You state: “Mondobiotech Aviptadil, expired.”

Patent US8178489B2:
2006-03-07 Application filed by MondoBiotech AG
2012-05-15 Application granted
Status Active - Reinstated
2029-07-03 Adjusted expiration

Likewise the PCT equivalent WO2006094764A1:
2006-03-07 Application filed by Mondobiotech Licensing Out Ag
2006-03-07 Priority claimed from DK06707454T
2006-03-07 Priority claimed from CN2006800072361A
2006-09-14 Publication of WO2006094764A1

Aren’t these patents still active?